Literature DB >> 15284337

Experimental Peptide Identification Repository (EPIR): an integrated peptide-centric platform for validation and mining of tandem mass spectrometry data.

Dan Bach Kristensen1, Jan Christian Brønd, Peter Aagaard Nielsen, Jens Roswald Andersen, Ole Tang Sørensen, Vibeke Jørgensen, Kenneth Budin, Jesper Matthiesen, Peter Venø, Hans Mikael Jespersen, Christian H Ahrens, Soeren Schandorff, Peder Thusgaard Ruhoff, Jacek R Wisniewski, Keiryn L Bennett, Alexandre V Podtelejnikov.   

Abstract

LC MS/MS has become an established technology in proteomic studies, and with the maturation of the technology the bottleneck has shifted from data generation to data validation and mining. To address this bottleneck we developed Experimental Peptide Identification Repository (EPIR), which is an integrated software platform for storage, validation, and mining of LC MS/MS-derived peptide evidence. EPIR is a cumulative data repository where precursor ions are linked to peptide assignments and protein associations returned by a search engine (e.g. Mascot, Sequest, or PepSea). Any number of datasets can be parsed into EPIR and subsequently validated and mined using a set of software modules that overlay the database. These include a peptide validation module, a protein grouping module, a generic module for extracting quantitative data, a comparative module, and additional modules for extracting statistical information. In the present study, the utility of EPIR and associated software tools is demonstrated on LC MS/MS data derived from a set of model proteins and complex protein mixtures derived from MCF-7 breast cancer cells. Emphasis is placed on the key strengths of EPIR, including the ability to validate and mine multiple combined datasets, and presentation of protein-level evidence in concise, nonredundant protein groups that are based on shared peptide evidence.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15284337     DOI: 10.1074/mcp.T400004-MCP200

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  7 in total

1.  Bayesian nonparametric model for the validation of peptide identification in shotgun proteomics.

Authors:  Jiyang Zhang; Jie Ma; Lei Dou; Songfeng Wu; Xiaohong Qian; Hongwei Xie; Yunping Zhu; Fuchu He
Journal:  Mol Cell Proteomics       Date:  2008-11-12       Impact factor: 5.911

2.  An integrated, directed mass spectrometric approach for in-depth characterization of complex peptide mixtures.

Authors:  Alexander Schmidt; Nils Gehlenborg; Bernd Bodenmiller; Lukas N Mueller; Dave Campbell; Markus Mueller; Ruedi Aebersold; Bruno Domon
Journal:  Mol Cell Proteomics       Date:  2008-05-29       Impact factor: 5.911

3.  Hierarchical clustering of shotgun proteomics data.

Authors:  Ville R Koskinen; Patrick A Emery; David M Creasy; John S Cottrell
Journal:  Mol Cell Proteomics       Date:  2011-03-29       Impact factor: 5.911

Review 4.  Plasma membrane proteomics and its application in clinical cancer biomarker discovery.

Authors:  Rikke Leth-Larsen; Rikke R Lund; Henrik J Ditzel
Journal:  Mol Cell Proteomics       Date:  2010-04-08       Impact factor: 5.911

5.  Directed shotgun proteomics guided by saturated RNA-seq identifies a complete expressed prokaryotic proteome.

Authors:  Ulrich Omasits; Maxime Quebatte; Daniel J Stekhoven; Claudia Fortes; Bernd Roschitzki; Mark D Robinson; Christoph Dehio; Christian H Ahrens
Journal:  Genome Res       Date:  2013-07-22       Impact factor: 9.043

6.  MASPECTRAS: a platform for management and analysis of proteomics LC-MS/MS data.

Authors:  Jürgen Hartler; Gerhard G Thallinger; Gernot Stocker; Alexander Sturn; Thomas R Burkard; Erik Körner; Robert Rader; Andreas Schmidt; Karl Mechtler; Zlatko Trajanoski
Journal:  BMC Bioinformatics       Date:  2007-06-13       Impact factor: 3.169

7.  Response of Burkholderia cenocepacia H111 to micro-oxia.

Authors:  Gabriella Pessi; Rubina Braunwalder; Alexander Grunau; Ulrich Omasits; Christian H Ahrens; Leo Eberl
Journal:  PLoS One       Date:  2013-09-02       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.